Jeih-san Liow

Dr. Jeih-san Liow


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 November 2006 in Synapse
Verified
Journal Article
Closed access
PDF file
JLJeih-san Liow
Jeih-san Liow
Shuiyu LuShuiyu Lu
Shuiyu Lu
JMJulie A. McCarron
Julie A. McCarron
JHJinsoo Hong
Jinsoo Hong
JMJohn L. Musachio
John L. Musachio
SZSami S. Zoghbi
Sami S. Zoghbi

17 December 2008 in Journal of Nuclear Medicine
Verified
Journal Article
Open access
PDF file
JLJeih-san Liow
Jeih-san Liow
WKWilliam Kreisl
William Kreisl
SZSami S. Zoghbi
Sami S. Zoghbi
NLNeva Lazarova
Neva Lazarova
NSNicholas Seneca
Nicholas Seneca
RIRobert B. Innis
Robert B. Innis
11C-Loperamide is an avid substrate for P-glycoprotein (P-gp), but it is rapidly metabolized to 11C-N-desmethyl-loperamide (11C-dLop), which is also a substrate for P-gp and thereby contaminates the radioactive signal in the brain. Should further demethylation of 11C-dLop occur, radiometabolites with low entry into the brain are generated. Therefore, we evaluated the ability of 11C-dLop to quantify the function of P-gp at the blood–brain barrier in monkeys. Methods: Six monkeys underwent 12 PET scans of the brain, 5 at baseline and 7 after pharmacologic blockade of P-gp. A subset of monkeys also underwent PET scans with 15O-water to measure cerebral blood flow. To determine whether P-gp blockade affected peripheral distribution of 11C-dLop, we measured whole-body biodistribution in 4 monkeys at baseline and after P-gp blockade. Results: The concentration of 11C-dLop in the brain was low under baseline conditions and increased 5-fold after P-gp blockade. This increase was primarily caused by an increased rate of entry into the brain rather than a decreased rate of removal from the brain. With P-gp blockade, uptake of radioactivity among brain regions correlated linearly with blood flow, suggesting a high single-pass extraction. After correction for cerebral blood flow, the uptake of 11C-dLop was fairly uniform among brain regions, suggesting that the function of P-gp is fairly uniformly distributed in the brain. On whole-body imaging, P-gp blockade significantly affected distribution of radioactivity only to the brain and not to other visually identified source organs. The effective dose estimated for humans was approximately 9 μSv/MBq. Conclusion: PET with 11C-dLop can quantify P-gp function at the blood–brain barrier in monkeys. The single-pass extraction of 11C-dLop is high and requires correction for blood flow to accurately measure the function of this efflux transporter. The low uptake at baseline and markedly increased uptake after P-gp blockade suggest that 11C-dLop will be useful to measure a wide range of P-gp functions at the blood–brain barrier in humans.

1 August 2004
Verified
Journal Article
Closed access
HTHiroshi Toyama
Hiroshi Toyama
MIMasanori Ichise
Masanori Ichise
JLJeih-san Liow
Jeih-san Liow
KMKendra J Modell
Kendra J Modell
DVDouglass C Vines
Douglass C Vines
RIRobert B Innis
Robert B Innis

1 September 2004
Verified
Journal Article
Closed access
JLJian-Qiang Lu
Jian-Qiang Lu
MIMasanori Ichise
Masanori Ichise
JLJeih-san Liow
Jeih-san Liow
SGSubroto Ghose
Subroto Ghose
DVDoug Vines
Doug Vines
RIRobert B Innis
Robert B Innis

1 September 2016 in NeuroImage
Verified
Journal Article
Closed access
JLJeih-san Liow
Jeih-san Liow
SZSami S. Zoghbi
Sami S. Zoghbi
SHShuo Hu
Shuo Hu
MHMatthew D. Hall
Matthew D. Hall
CHChristina S. Hines
Christina S. Hines
RIRobert B. Innis
Robert B. Innis

1 September 2003
Verified
Journal Article
Closed access
DVDouglass C Vines
Douglass C Vines
MIMasanori Ichise
Masanori Ichise
JLJeih-san Liow
Jeih-san Liow
HTHiroshi Toyama
Hiroshi Toyama
RIRobert B Innis
Robert B Innis